These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 3496089

  • 41. Antiviral activity of mismatched double-stranded RNA against human immunodeficiency virus in vitro.
    Montefiori DC, Mitchell WM.
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2985-9. PubMed ID: 3106982
    [Abstract] [Full Text] [Related]

  • 42. Uptake of 2',3'-dideoxyadenosine in human immunodeficiency virus-infected and noninfected human cells.
    Agarwal RP, Busso ME, Mian AM, Resnick L.
    AIDS Res Hum Retroviruses; 1989 Oct; 5(5):541-50. PubMed ID: 2590557
    [Abstract] [Full Text] [Related]

  • 43. Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus.
    Matsukura M, Shinozuka K, Zon G, Mitsuya H, Reitz M, Cohen JS, Broder S.
    Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7706-10. PubMed ID: 3499613
    [Abstract] [Full Text] [Related]

  • 44. Cell-dependent interference of a series of new 6-aminoquinolone derivatives with viral (HIV/CMV) transactivation.
    Stevens M, Balzarini J, Tabarrini O, Andrei G, Snoeck R, Cecchetti V, Fravolini A, De Clercq E, Pannecouque C.
    J Antimicrob Chemother; 2005 Nov; 56(5):847-55. PubMed ID: 16150861
    [Abstract] [Full Text] [Related]

  • 45. 9-[(2RS)-3-fluoro-2-phosphonylmethoxypropyl] derivatives of purines: a class of highly selective antiretroviral agents in vitro and in vivo.
    Balzarini J, Holy A, Jindrich J, Dvorakova H, Hao Z, Snoeck R, Herdewijn P, Johns DG, De Clercq E.
    Proc Natl Acad Sci U S A; 1991 Jun 01; 88(11):4961-5. PubMed ID: 1711214
    [Abstract] [Full Text] [Related]

  • 46. Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.
    Perno CF, Yarchoan R, Cooney DA, Hartman NR, Gartner S, Popovic M, Hao Z, Gerrard TL, Wilson YA, Johns DG.
    J Exp Med; 1988 Sep 01; 168(3):1111-25. PubMed ID: 2844951
    [Abstract] [Full Text] [Related]

  • 47. Muramyl dipeptide inhibits replication of human immunodeficiency virus in vitro.
    Masihi KN, Lange W, Rohde-Schulz B, Chedid L.
    AIDS Res Hum Retroviruses; 1990 Mar 01; 6(3):393-9. PubMed ID: 2111159
    [Abstract] [Full Text] [Related]

  • 48. Prostaglandin A inhibits replication of human immunodeficiency virus during acute infection.
    Ankel H, Turriziani O, Antonelli G.
    J Gen Virol; 1991 Nov 01; 72 ( Pt 11)():2797-800. PubMed ID: 1940869
    [Abstract] [Full Text] [Related]

  • 49. Adenosine inhibits prolactin and growth hormone secretion in a clonal pituitary cell line.
    Dorflinger LJ, Schonbrunn A.
    Endocrinology; 1985 Dec 01; 117(6):2330-8. PubMed ID: 2998734
    [Abstract] [Full Text] [Related]

  • 50. Permeation and salvage of dideoxyadenosine in mammalian cells.
    Plagemann PG, Woffendin C.
    Mol Pharmacol; 1989 Jul 01; 36(1):185-92. PubMed ID: 2787472
    [Abstract] [Full Text] [Related]

  • 51. Pharmacokinetics of 2',3'-dideoxyadenosine in dogs.
    Wientjes MG, Placke ME, Chang MJ, Page JG, Kluwe WM, Tomaszewski JE.
    Invest New Drugs; 1991 May 01; 9(2):159-68. PubMed ID: 1908444
    [Abstract] [Full Text] [Related]

  • 52. Synthesis of 2',3'-dideoxynucleosides by enzymatic trans-glycosylation.
    Carson DA, Wasson DB.
    Biochem Biophys Res Commun; 1988 Sep 15; 155(2):829-34. PubMed ID: 3262341
    [Abstract] [Full Text] [Related]

  • 53. Adenine and deazaadenine nucleoside and deoxynucleoside analogues: inhibition of viral replication of sheep MVV (in vitro model for HIV) and bovine BHV-1.
    Salvatori D, Volpini R, Vincenzetti S, Vita A, Costanzi S, Lambertucci C, Cristalli G, Vittori S.
    Bioorg Med Chem; 2002 Sep 15; 10(9):2973-80. PubMed ID: 12110319
    [Abstract] [Full Text] [Related]

  • 54. Enzymatic properties of the unnatural beta-L-enantiomers of 2',3'-dideoxyadenosine and 2',3'-didehydro-2',3'-dideoxyadenosine.
    Pélicano H, Pierra C, Eriksson S, Gosselin G, Imbach JL, Maury G.
    J Med Chem; 1997 Nov 21; 40(24):3969-73. PubMed ID: 9397178
    [Abstract] [Full Text] [Related]

  • 55. Derivatives of 3'- and 5'-deoxyadenosine: their inhibitory activity against DNA viruses.
    Grytzmann B, Morr M, Wigand R.
    Chemotherapy; 1980 Nov 21; 26(5):316-22. PubMed ID: 6967001
    [Abstract] [Full Text] [Related]

  • 56. Agents for treating human immunodeficiency virus infection.
    Acosta EP, Fletcher CV.
    Am J Hosp Pharm; 1994 Sep 15; 51(18):2251-67; quiz 2286-7. PubMed ID: 7801986
    [Abstract] [Full Text] [Related]

  • 57. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.
    Furman PA, Fyfe JA, St Clair MH, Weinhold K, Rideout JL, Freeman GA, Lehrman SN, Bolognesi DP, Broder S, Mitsuya H.
    Proc Natl Acad Sci U S A; 1986 Nov 15; 83(21):8333-7. PubMed ID: 2430286
    [Abstract] [Full Text] [Related]

  • 58. [Inhibition of human immunodeficiency virus replication by azidothymidine (Azitidín Lachema) in cultured cells].
    Schmidtmayerová H, Mayer V.
    Bratisl Lek Listy; 1993 Feb 15; 94(2):76-80. PubMed ID: 7689030
    [Abstract] [Full Text] [Related]

  • 59. [Synthesis of a novel L-nucleoside, beta-L-D4A and its inhibition on the replication of hepatitis B virus in vitro].
    Wu JM, Lin JS, Xie N, Qiu GF, Hu XM.
    Yao Xue Xue Bao; 2005 Sep 15; 40(9):825-9. PubMed ID: 16342685
    [Abstract] [Full Text] [Related]

  • 60. cycloSal-Pronucleotides of 2',3'-dideoxyadenosine and 2', 3'-dideoxy-2',3'-didehydroadenosine: synthesis and antiviral evaluation of a highly efficient nucleotide delivery system.
    Meier C, Knispel T, De Clercq E, Balzarini J.
    J Med Chem; 1999 May 06; 42(9):1604-14. PubMed ID: 10229629
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.